Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
Article Details
- CitationCopy to clipboard
Kador PF, Kinoshita JH, Sharpless NE
Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
J Med Chem. 1985 Jul;28(7):841-9.
- PubMed ID
- 3925146 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drugs
- Binding Properties
Drug Target Property Measurement pH Temperature (°C) Alrestatin Aldose reductase IC 50 (nM) 79000 N/A N/A Details Alrestatin Aldose reductase IC 50 (nM) 34000 N/A N/A Details Alrestatin Aldose reductase IC 50 (nM) 6500 N/A N/A Details Alrestatin Aldose reductase IC 50 (nM) 22000 N/A N/A Details Alrestatin Aldose reductase IC 50 (nM) 140000 N/A N/A Details Sorbinil Aldose reductase IC 50 (nM) 700 N/A N/A Details Sorbinil Aldose reductase IC 50 (nM) 2200000 N/A N/A Details Sorbinil Aldose reductase IC 50 (nM) 1400000 N/A N/A Details Sorbinil Aldose reductase IC 50 (nM) 7200 N/A N/A Details Sorbinil Aldose reductase IC 50 (nM) 4700 N/A N/A Details